Paper · 20172905
In situ trans ligands of CD22 identified by glycan-protein photocross-linking-enabled proteomics.
Ramya TN and 8 others. Mol Cell Proteomics, 2010. Cited by 63 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. In situ trans ligands of CD22 identified by glycan-protein photocross-linking-enabled proteomics. Papers, record 20172905. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/20172905
On this page
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- In situ trans ligands of CD22 identified by glycan-protein photocross-linking-enabled proteomics.
- PubMed
Topics21
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Cross-Linking Reagents | Major topic |
| Glycoproteins | Major topic |
| Proteomics | Major topic |
| Sialic Acid Binding Ig-like Lectin 2 | Major topic |
| Ultraviolet Rays | Major topic |
| Animals | |
| B-Lymphocytes | |
| CHO Cells | |
| Cell Communication | |
| Cell Membrane | |
| Cricetinae | |
| Cricetulus | |
| Humans | |
| Immunoglobulin M | |
| Immunohistochemistry | |
| Isotope Labeling | |
| Ligands | |
| Mass Spectrometry | |
| Mice | |
| Reproducibility of Results | |
| Sialic Acids |
Source PubMed
Grants10
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| AI50143 | NIAID NIH HHS | United States | R01AI050143 | PubMed and NIH | NIH RePORTER |
| P41 RR011823 | NCRR NIH HHS | United States | P41RR011823 | PubMed and NIH | NIH RePORTER |
| P30 NS057096 | NINDS NIH HHS | United States | P30NS057096 | PubMed and NIH | NIH RePORTER |
| GM60938 | NIGMS NIH HHS | United States | R01GM060938 | PubMed and NIH | NIH RePORTER |
| R01 CA087660 | NCI NIH HHS | United States | R01CA087660 | PubMed and NIH | NIH RePORTER |
| R37 CA087660 | NCI NIH HHS | United States | R01CA087660 | PubMed and NIH | NIH RePORTER |
| R01 AI050143 | NIAID NIH HHS | United States | R01AI050143 | PubMed and NIH | NIH RePORTER |
| P30NS057096 | NINDS NIH HHS | United States | P30NS057096 | PubMed and NIH | NIH RePORTER |
| R01 GM060938 | NIGMS NIH HHS | United States | R01GM060938 | PubMed and NIH | NIH RePORTER |
| R37CA087660 | NIH | NIH RePORTER |
Trials0
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
None in this release.
Comments and corrections0
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
None in this release.
References71
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 1,691,828 | The B-cell antigen CD22 mediates monocyte and erythrocyte adhesion. | Nature | 1990 | https://conductscience.org/library/papers/1691828 | PubMed |
| 2 | 1,717,156 | The B lymphocyte adhesion molecule CD22 interacts with leukocyte common antigen CD45RO on T cells and alpha 2-6 sialyltransferase, CD75, on B cells. | Cell | 1991 | https://conductscience.org/library/papers/1717156 | PubMed |
| 3 | 19,594,627 | Endogenous ligands for C-type lectin receptors: the true regulators of immune homeostasis. | Immunol Rev | 2009 | https://conductscience.org/library/papers/19594627 | PubMed |
| 4 | 11,231,557 | Large-scale analysis of the yeast proteome by multidimensional protein identification technology. | Nat Biotechnol | 2001 | https://conductscience.org/library/papers/11231557 | PubMed |
| 5 | 16,408,005 | Homomultimeric complexes of CD22 in B cells revealed by protein-glycan cross-linking. | Nat Chem Biol | 2005 | https://conductscience.org/library/papers/16408005 | PubMed |
| 6 | 12,643,522 | DTASelect and Contrast: tools for assembling and comparing protein identifications from shotgun proteomics. | J Proteome Res | 2002 | https://conductscience.org/library/papers/12643522 | PubMed |
| 7 | 12,118,079 | Stable isotope labeling by amino acids in cell culture, SILAC, as a simple and accurate approach to expression proteomics. | Mol Cell Proteomics | 2002 | https://conductscience.org/library/papers/12118079 | PubMed |
| 8 | 10,911,380 | Quantitative flow cytometry for the differential diagnosis of leukemic B-cell chronic lymphoproliferative disorders. | Am J Hematol | 2000 | https://conductscience.org/library/papers/10911380 | PubMed |
| 9 | 19,234,450 | High-efficiency labeling of sialylated glycoproteins on living cells. | Nat Methods | 2009 | https://conductscience.org/library/papers/19234450 | PubMed |
| 10 | 19,202,057 | Sialylated multivalent antigens engage CD22 in trans and inhibit B cell activation. | Proc Natl Acad Sci U S A | 2009 | https://conductscience.org/library/papers/19202057 | PubMed |
1 to 10 of 71
See all 71 referencesCited by48
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 63 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 40,067,740 | Structure of the CD33 Receptor and Implications for the Siglec Family. | Biochemistry | 2025 | https://conductscience.org/library/papers/40067740 | PubMed |
| 39,805,041 | Quantitative Glycan-Protein Cross-Linking Mass Spectrometry Using Enrichable Linkers Reveals Extensive Glycan-Mediated Protein Interaction Networks. | Anal Chem | 2025 | https://conductscience.org/library/papers/39805041 | PubMed |
| 39,710,139 | Photocrosslinking and capture for the analysis of carbohydrate-dependent interactions. | Bioorg Med Chem Lett | 2025 | https://conductscience.org/library/papers/39710139 | PubMed |
| 37,821,931 | Targeting CD22 for B-cell hematologic malignancies. | Exp Hematol Oncol | 2023 | https://conductscience.org/library/papers/37821931 | PubMed |
| 37,498,177 | A photoaffinity glycan-labeling approach to investigate immunoglobulin glycan-binding partners. | Glycobiology | 2023 | https://conductscience.org/library/papers/37498177 | PubMed |
| 37,413,923 | Siglecs as potential targets of therapy in human mast cell- and/or eosinophil-associated diseases. | Semin Immunol | 2023 | https://conductscience.org/library/papers/37413923 | PubMed |
| 37,131,487 | (Glycan Binding) Activity-Based Protein Profiling in Cells Enabled by Mass Spectrometry-Based Proteomics. | Isr J Chem | 2023 | https://conductscience.org/library/papers/37131487 | PubMed |
| 36,609,645 | A (cross)link in the chains. | Nat Chem | 2023 | https://conductscience.org/library/papers/36609645 | PubMed |
| 36,493,526 | Proximity labeling technologies to illuminate glycan-protein interactions. | Curr Opin Chem Biol | 2023 | https://conductscience.org/library/papers/36493526 | PubMed |
| 36,425,332 | NEU1 and NEU3 enzymes alter CD22 organization on B cells. | Biophys Rep (N Y) | 2022 | https://conductscience.org/library/papers/36425332 | PubMed |
1 to 10 of 48
See all 48 cited byGenes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| CD22 | 933 | Swiss-Prot's references | https://conductscience.org/library/genes/933 |
Source NCBI Gene
Drugs0
The drugs whose trials, in the Pipelines release, list the paper.
None in this release.
Data0
The data bank entries PubMed's record names. Trial numbers are under Trials.
None in this release.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/20172905
GET https://conductscience.org/api/papers/v1/20172905/references?page=2